MMP9 expression is regulated by several pathways and epigenetic alterations [44,45,46]; overexpression is due to the aberrant activation of the MAPK and AKT/mTOR signaling pathways almost always found in melanoma [47,48]. This evidence concerns the gene AKT1 and melanoma.